BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Fujirebio Diagnostics, Inc. 

201 Great Valley Parkway

Malvern  Pennsylvania  19355-1307  U.S.A.
Phone: 610-240-3800 Fax: 610-240-3803


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Fujirebio Diagnostics, Inc. CEO Paul Touhey Joins Invisible Sentine's Board of Directors 10/22/2012 9:08:37 AM    More...
Gold Standard Diagnostics Extends Relationship with Fujirebio Diagnostics, Inc. and Signs an Exclusive US Distribution Agreement for Cyfra 21-1 EIA 10/17/2011 10:43:57 AM    More...
FDA OKs Fujirebio Diagnostics, Inc.'s Next-Generation Biomarker Test to Determine Likelihood of Ovarian Cancer in Women Who Present with Adnexal Mass 9/6/2011 7:53:29 AM    More...
Gold Standard Diagnostics Signs U.S. Distribution Agreement With Fujirebio Diagnostics, Inc. for Multi-Constituent Tumor Marker Control 7/13/2011 10:29:19 AM    More...
Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer 5/31/2011 9:09:07 AM    More...
Fujirebio Diagnostics, Inc. Snaps Up Offloaded Abbott Diagnostics Unit 7/21/2010 7:07:54 AM    More...
Becton, Dickinson and Company (BDX) and Fujirebio Diagnostics, Inc. Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management 5/4/2009 6:40:55 AM    More...
Fujirebio Diagnostics, Inc. Appoints Grady Barnes as Chief Scientific Officer 3/23/2009 10:45:14 AM    More...
Fujirebio Diagnostics, Inc. Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer 2/11/2009 10:56:01 AM    More...
Fujirebio Diagnostics, Inc. and Abbott Laboratories (ABT) Agree To Develop New Ovarian Cancer Test for Abbott's Architect(R) Analyzers 1/27/2009 8:20:07 AM    More...
123